Core Laboratories NV (NYSE:CLB) had its price objective raised by Citigroup Inc. from $110.00 to $115.00 in a note issued to investors on Tuesday. The firm presently has a “neutral” rating on the stock. Citigroup Inc.’s price target would indicate a potential upside of 0.50% from the stock’s current price.

Several other equities research analysts have also recently issued reports on CLB. DA Davidson began coverage on Core Laboratories NV in a research note on Wednesday, October 5th. They set a “buy” rating and a $136.00 target price for the company. KLR Group reaffirmed a “buy” rating and issued a $180.00 price objective (up from $166.00) on shares of Core Laboratories NV in a research note on Monday, June 13th. Zacks Investment Research cut Core Laboratories NV from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 26th. Credit Suisse Group AG assumed coverage on Core Laboratories NV in a research note on Thursday, September 1st. They issued a “neutral” rating and a $115.00 price objective for the company. Finally, Loop Capital assumed coverage on Core Laboratories NV in a research note on Friday, September 30th. They issued a “hold” rating and a $120.00 price objective for the company. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $121.61.

Analyst Recommendations for Core Laboratories NV (NYSE:CLB)

Core Laboratories NV (NYSE:CLB) traded down 0.38% during midday trading on Tuesday, reaching $114.00. The company’s stock had a trading volume of 179,282 shares. Core Laboratories NV has a 1-year low of $84.50 and a 1-year high of $135.49. The firm has a market capitalization of $5.03 billion, a PE ratio of 60.48 and a beta of 1.45. The stock’s 50-day moving average price is $111.09 and its 200 day moving average price is $117.57.

Core Laboratories NV (NYSE:CLB) last posted its earnings results on Wednesday, July 20th. The company reported $0.35 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.35. The company earned $148.10 million during the quarter, compared to analysts’ expectations of $146.37 million. Core Laboratories NV had a return on equity of 344.55% and a net margin of 11.81%. The firm’s quarterly revenue was down 27.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.81 earnings per share. Equities analysts anticipate that Core Laboratories NV will post $1.54 EPS for the current fiscal year.

Hedge funds have recently bought and sold shares of the stock. Balentine LLC increased its stake in Core Laboratories NV by 44.3% in the second quarter. Balentine LLC now owns 893 shares of the company’s stock valued at $111,000 after buying an additional 274 shares during the last quarter. MU Investments Co. Ltd. purchased a new stake in Core Laboratories NV during the second quarter valued at $115,000. Advisory Services Network LLC increased its stake in Core Laboratories NV by 33.2% in the third quarter. Advisory Services Network LLC now owns 1,062 shares of the company’s stock valued at $119,000 after buying an additional 265 shares during the last quarter. Pinkerton Retirement Specialists LLC purchased a new stake in Core Laboratories NV during the second quarter valued at $127,000. Finally, Fifth Third Bancorp increased its stake in Core Laboratories NV by 15.3% in the second quarter. Fifth Third Bancorp now owns 1,166 shares of the company’s stock valued at $144,000 after buying an additional 155 shares during the last quarter.

About Core Laboratories NV

Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase oil and gas recovery from their producing fields.

5 Day Chart for NYSE:CLB

Receive News & Stock Ratings for Core Laboratories NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories NV and related stocks with our FREE daily email newsletter.